Keywords: ec, clears, medicines, co, angiox, european, commission

EC clears Medicines Co's Angiox

Article | 04 October 2004

The European Commission has cleared The Medicines Company's direct thrombin inhibitor Angiox (bivalirudin) as an anticoagulant in patients undergoing percutaneous ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Nycomed

Go to company listing

Related Drugs

Angiomax

Bivalirudin

Go to drug listing